相关实验视频

Updated: Jan 14, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

染色恐惧性细胞癌:新兴的脆弱性作为新疗法景观的承诺

Samer Salem¹, Michel Alchoueiry¹, Wenxin Xu²

¹Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Critical reviews in oncology/hematology

|October 24, 2025

概括

染色恐惧性细胞癌 (ChRCC) 研究揭示了独特的生物学和脆弱性. 针对CHRCC特异性特征的有希望的新疗法正在出现,为改善患者的治疗结果提供了希望.

科学领域:

在瘤学瘤学.
细胞癌的亚型细胞癌的亚型
癌症生物学癌症生物学

背景情况:

染色恐惧性细胞癌 (ChRCC) 是一种罕见的,独特的细胞癌亚型.
慢性肺癌的特点是瘤突变负担较低,线粒体异常和独特的代谢依赖.
从历史上看,CHRCC由于其分类和试验排除而缺乏量身定制的治疗选择.

研究的目的:

审查新出现的临床试验数据免疫检查点和氨酸激酶抑制剂在CHRCC.
突出CHRCC特有的治疗弱点和有前途的新型治疗策略.
强调对CHRCC患者进行生物学信息,包容性临床试验的必要性.

主要方法:

审查最近的临床试验数据和科学文献.
对CHRCC特有的生物学特征和潜在的治疗点的分析.
识别新兴的治疗途径,包括ferroptosis诱导,KIT向的ADC和NK细胞疗法.

主要成果:

免疫检查点和氨酸激酶抑制剂在CHRCC中表现出不同的疗效.
新出现的数据表明,CHRCC中存在明显的治疗漏洞.
三个有前途的途径包括ferroptosis诱导,KIT向抗体-药物合体和自然杀手采用细胞疗法.

结论:

冠状癌细胞生物学需要量身定制的治疗方法,超越传统的非清晰细胞分类.
针对ChRCC特定的漏洞提供了有前途的新治疗策略.
多专业的协作和基于生物学的试验对于推进CHRCC患者的治疗结果至关重要.

关键词:

染色恐惧性细胞癌临床试验中的临床试验.结合结合结合结合结合结合结合新兴的治疗方法铁化是铁化的一种.免疫基因组学是什么 KIT抗体-药物可以使用.脏癌症是什么? 脏癌症是什么自然杀手细胞采用疗法

更多相关视频

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...